|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项
! Q/ }$ O: D1 |' P6 i01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.. O3 y2 ?0 C$ ?3 s' u7 J% s8 d% }+ s
02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor.- G2 _2 I6 c! N2 N+ P: ~
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.$ g) S# |: J0 W) @7 v7 y
04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.) M- {7 O9 ~; H# I
05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study., A" o9 n, g0 L0 J8 B3 h' k
06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.2 i7 [& l$ M6 G5 ~! ?# W1 _
07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.
% [+ f$ \ ~. f2 r08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.
/ G1 w2 X8 A3 c, _6 n09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
; K: n7 \% s4 [10.Interpretable machine learning for prostate biopsy: Cohort study.
* D! U% ]) U3 D+ z' l9 @0 i' m11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.% r* d" c+ e) Y, e! n
12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.3 A. Q! T) v: c3 n& u( d
13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).: b) t$ |5 A" c0 M: `
14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).
2 w$ E/ T* O( ~8 @ ]15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.
8 @* d# S4 v: W0 ]) l6 d( b16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.6 _ w5 p' N1 O2 [
17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors./ t0 J, @/ Q6 s
18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift./ W% E8 |$ F* w2 f8 Y* g) X; H; p
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.
( a4 v. g/ q# V* {20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.& _. }# J# n# w
21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.
; K2 N! g' ?" R* t22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.
, ]9 s# u" T; l4 {23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.& ]4 Y$ t2 k: t6 `% r9 j. d
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.
3 T5 O7 E h2 L" J& z- K3 L* Y25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.% {7 u5 B m. k5 ]8 R6 D
|
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
